Eligible participants were assigned to a systolic
blood-pressure target of either less than
140 mm Hg (the standard-treatment group) or
less than 120 mm Hg (the intensive-treatment
group). Randomization was stratified according
to clinical site. Participants and study personnel
were aware of the study-group assignments, but
outcome adjudicators were not